GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Krishna Institute of Medical Sciences Ltd

KIMS Hospitals: Board Renews Director Appointments for 5 Years

MANAGEMENT ● No Immediate Change LOW RISK
📅 Filed on BSE: 04 Nov 2026, 08:34 PM IST  ·  BSE ID: 93844078-e8c3-407e-83b9-58770ccea72b
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's leadership team, including its CEO and Chairman, has had their terms extended by the Board of Directors for five more years.
🤖 AI Summary
  • KIMS Hospitals Board re-appointed key directors for a new 5-year term.
  • Dr. Abhinay Bollineni continues as Director & CEO for five years.
  • Dr. Bhaskara Rao Bollineni continues as Chairman & Managing Director for five years.
  • Ms. Dandamudi Anitha re-appointed as Whole-time Director for five years.
🏢 How This Affects the Company
📈
Business Impact
The re-appointments signal continuity in leadership and strategy for Krishna Institute of Medical Sciences Ltd.
💰
Financial Impact
No immediate financial impact is disclosed from these management re-appointments.
⚙️
Operational Impact
Leadership stability is maintained with these executive re-appointments.
⚠️
Risk Impact
No new risks are introduced by these routine management re-appointments.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders regarding these re-appointments.
👤
Who Is Affected
All shareholders are affected by the continuity in the company's senior management team.
🔍
Management Signal
The re-appointments indicate management's intention to maintain its current leadership structure and strategic direction.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Next board meeting agenda for strategic updates.
Annual general meeting disclosures on executive remuneration.
Company's future business expansion plans under renewed leadership.
LOW RISK These are routine re-appointments of existing directors, indicating stability.
💡 Investor Takeaway
Krishna Institute of Medical Sciences Ltd. has renewed the appointments of its Director & CEO, Chairman & Managing Director, and a Whole-time Director for a further 5-year term.
❓ Frequently Asked Questions
Who has been re-appointed to key positions at Krishna Institute of Medical Sciences Ltd.?
Dr. Abhinay Bollineni as Director & CEO, Dr. Bhaskara Rao Bollineni as Chairman & Managing Director, and Ms. Dandamudi Anitha as Whole-time Director have been re-appointed.
What is the term for the re-appointments at KIMS Hospitals?
All re-appointments are for a further term of 5 years.
When was the Board of Directors meeting held for these re-appointments?
The Board of Directors meeting where these re-appointments were approved was held on November 04, 2026.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.